Holen Sie sich die Stockscreener-App
118.64
10.48%
11.25
Handel nachbörslich:
116.80
-1.84
-1.55%
Revolution Medicines Inc Aktie (RVMD) Neueste Nachrichten
Why Revolution Medicines stock surged by 11% today - MSN
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus - TechStock²
AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next - TechStock²
Why Revolution Medicines Stock Surged by 11% Today - The Motley Fool
Insider Sell: Jack Anders Sells 10,000 Shares of Revolution Medi - GuruFocus
Merck Looks To Buy Cancer Drugmaker Revolution Medicines As Keytruda Nears Patent Expiry: Report - Stocktwits
Revolution Medicines jumps on report AbbVie nears takeover - MSN
RVMD Stock Soars 11% After Reports Of Near $30B Buyout Talks With Merck - Stocktwits
Revolution Medicines (NASDAQ:RVMD) CFO Jack Anders Sells 10,000 Shares - MarketBeat
Margaret Horn Sells 75,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat
Merck buyout chatter jolts Revolution Medicines (RVMD) stock after FDA breakthrough nod - TechStock²
Revolution Medicines Soars Amid AbbVie Acquisition Talks - StocksToTrade
Merck (MRK) Eyes Acquisition of Revolution Medicines (RVMD) for $30 Billion - GuruFocus
Merck Reportedly in Talks to Acquire Revolution Medicines (RVMD) - GuruFocus
Merck (MRK) Eyes $30 Billion Acquisition of Revolution Medicines - GuruFocus
Revolution Medicines stock soars on report of AbbVie takeover - MSN
STAT’s Adam Feuerstein says Revolution Medicines canceled meeting - TipRanks
Merck in Talks to Buy Revolution Medicines Per Financial Times Report - sharewise.com
Key facts: Merck in talks to acquire Revolution Medicines; seeks data on child vaccines - TradingView — Track All Markets
Merck in Talks to Buy Revolution Medicines for Around $30 Billion - The Wall Street Journal
Revolution Medicines: "Strong Buy" As Acquisition Prospects Continue To Circle (RVMD) - Seeking Alpha
Revolution Medicines stock rises as Merck buyout talks swirl; FDA designation adds another spark - TechStock²
Revolution Medicines Stock Drops After-Hours On AbbVie Denying Acquisition Talks - Stocktwits
Merck (MRK) Considers Multi-Billion Dollar Acquisition of Revolu - GuruFocus
Revolution Medicines (NASDAQ:RVMD) Shares Gap UpShould You Buy? - MarketBeat
Merck Eyes Revolution Medicines in a Potential $32 Billion Deal - GuruFocus
Revolution Medicines Stock Jumps. Takeover Buzz Grows, Another Suitor Emerges. - Barron's
Revolution Medicines: Pivotal Trial Readouts Coming, And Buyout Rumors Churning (RVMD) - Seeking Alpha
Merck & Co is accelerating the expansion of its oncology pipeline and is reportedly planning to acquire a cutting-edge pharmaceutical company for $30 billion. - 富途牛牛
Wedbush lifts Revolution Medicines PT as Merck takeover talks heat up - TradingView — Track All Markets
Stock Movers: Meta, Revolution Medicines, GM - Bloomberg.com
Speculation builds about a multibillion-dollar takeout of Revolution Medicines - Endpoints News
Merck in Talks to Buy Biotech Revolution Medicines, FT Says - Bloomberg.com
M&A News: Revolution Medicines (RVMD) Stock Rallies on News of Potential Acquisition by Merck - TipRanks
Rocket Cos., Opendoor, GM, Apple, Glencore, Revolution Medicines, Tilray, and More Movers - Barron's
Report says MSD is in talks to buy Revolution Meds - pharmaphorum
Merck in talks to buy Revolution Medicines, shares jump 16% By Investing.com - Investing.com Australia
Merck in talks to buy Revolution Medicines, shares jump 16% - Investing.com
Merck reportedly consiering a major acquisition (Revolution Medicines) - MarketScreener
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal - Medical Dialogues
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga
Merck Reportedly in Talks to Buy Revolution in Up to $32 Billion Deal - MarketScreener
Revolution Medicines Stock Pre-Market (+15%) : FDA Grants Breakthrough Therapy Designation for Zoldonrasib - Trefis
RVMD stock hits a record high on rumored takeover interest - MSN
Merck in talks to buy biotech Revolution Medicines, FT reports - 1470 & 100.3 WMBD
Merck Reportedly In Talks to Buy Biotech Firm Revolution Medicines for Up to US$32B - AASTOCKS.com
Is It Too Late To Consider Revolution Medicines (RVMD) After Its Recent Share Price Surge? - simplywall.st
US Stock Movement | Revolution Medicines Surges Over 13% in After-Hours Trading Amid Reports of Acquisition Talks with Merck for Up to $32 Billion - Bitget
FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug - Investing.com Nigeria
Revolution Medicines takeout speculation spotlight shines on Merck & Co. - FirstWord
What sentiment indicators say about Revolution Medicines Inc. stockDividend Yield Trends & Free Stock Trading Signal Access - bollywoodhelpline.com
Merck, not AbbVie, in talks to buy biotech Revolution Medicines, FT says - Crain's Chicago Business
Merck (MRK) Eyes Acquisition of Revolution Medicines (RVMD) - GuruFocus
Revolution Medicines Stock Soars: Time to Buy? - timothysykes.com
Merck in talks to buy biotech Revolution in up to $32 billion deal, FT reports - Reuters
Revolution Medicines soars on report Merck in talks to buy (update) (RVMD:NASDAQ) - Seeking Alpha
Why Revolution Medicines’ Stock Is Suddenly Under Pressure - TipRanks
Price tag of $28bn to $32bn was being discussed as part of Merck-Revolution Medicines dealFT - MarketScreener
Merck (MRK) Engages in Acquisition Talks with Revolution Medicines - GuruFocus
Merck might buy Revolution Medicines - breakingthenews.net
Merck in talks to buy biotech Revolution Medicines, FT reports By Reuters - Investing.com
Revolution Medicines stock rises on Merck acquisition talks By Investing.com - Investing.com Nigeria
Revolution Medicines stock rises on Merck acquisition talks - Investing.com
Merck in Deal Talks With Biotech Revolution Medicines, FT Says - Bloomberg.com
Why Revolution Medicines Inc. Equity Warrant stock remains resilient2025 Bull vs Bear & Proven Capital Preservation Methods - ulpravda.ru
Merck in talks to buy biotech Revolution Medicines, Financial Times reports - TradingView — Track All Markets
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn - Financial Times
Will Revolution Medicines Inc. Equity Warrant stock deliver shareholder value2025 Support & Resistance & Stepwise Swing Trade Plans - ulpravda.ru
1.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):